Inventor · disambiguated record
Parsa Akbari
Also filed as: AKBARI PARSA
5 granted patents·5 pending applications·7 citations·filing 2021–2024
72Inventor score
Top patents by PatentIndex Score
10 records- 0192US11957704B2Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitorsREGENERON PHARMA·Filed 2022·Granted Apr 16, 2024·2 cites·11 claims
- 0292US11939635B2Treatment of obesity in subjects having variant nucleic acid molecules encoding Calcitonin Receptor (CALCR)REGENERON PHARMA·Filed 2021·Granted Mar 26, 2024·2 cites·20 claims
- 0391US11759476B2Methods of treating metabolic disorders and cardiovascular disease with Inhibin Subunit Beta E (INHBE) inhibitorsREGENERON PHARMA·Filed 2022·Granted Sep 19, 2023·2 cites·16 claims
- 0485US11359246B2Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitorsREGENERAN PHARMACEUTICALS INC·Filed 2021·Granted Jun 14, 2022·1 cites·29 claims
- 0581US2024252528A1Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (INHBE) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0674US2024182973A1Treatment Of Obesity In Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR)REGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0773US2025188473A1Methods Of Treating Liver Diseases With Phosphodiesterase 3B (PDE3B) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0872US2022184114A1Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (INHBE) InhibitorsREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 0970US12123001B2Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitorsREGENERON PHARMA·Filed 2022·Granted Oct 22, 2024·0 cites·14 claims
- 1066US2022411870A1Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Parsa Akbari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →